Utidelone capsule 40mg/m2/d BID for fallopian tube neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Jun 2025: Trial registered, NCT07044349

The trials

NCT07044349: Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

State
Not started
Phase
Phase 2
People
72 planned
Started
Sep 2025
Primary completion
Mar 2027
Arms
Cohort 2 initial group
Results
None posted
  1. 30 Jun 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.